Cory Nicholas

Cory Nicholas

Company: NeuronaTx

Job title: Chief Executive Officer


Uncovering Targeted Neural Cell Therapies for Chronic Disorders of the Nervous System 5:00 pm

Developing neuronal cell therapy targeting dysregulated neural activity as a broad opportunity for the potential treatment of multiple neurodegenerative and developmental disorders Revealing NRTX-1001: an inhibitory neuron cell therapy for chronic focal epilepsy (Phase I/II; NCT05135091) Examining the preclinical evaluation of NRTX-1001 for Alzheimer’s diseaseRead more

day: Day 2 afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.